Thermo Fisher Scientific (NYSE:TMO) announced on Wednesday that it has launched its latest line of ultra-low temperature (ULT) freezers, the Thermo Scientific TSX Universal Series ULT Freezers. These freezers offer enhanced performance, tighter temperature control and faster recovery times, supporting quality and sustainability goals in laboratory settings.
With Universal V-Drive technology, the TSX Universal Series adapts to various lab workflows, from academic labs to long-term storage facilities, while delivering industry-leading performance and energy efficiency. They undergo rigorous reliability testing and are ENERGY STAR certified, designed with sustainability in mind and providing environmental impact information through the ACT label program.
The TSX Series ULT platform introduces medical device units for freezing blood and blood products, catering to users in GMP or qualified environments. Additionally, achieving ISO Class 5.5 cleanroom designation ensures cleanliness and control for cell and gene therapy customers.
Thermo Fisher Scientific, with annual revenue exceeding USD40bn, is dedicated to enabling customers to make the world healthier, cleaner and safer through innovative technologies and pharmaceutical services.
Healthcare Holding Schweiz AG acquires Effectum CH-Rep AG to expand services
Femasys receives CE mark approval for FemBloc delivery system in Europe
Aiforia secures IVDR certification for expanded AI-powered cancer diagnostics in Europe
Limaca Medical launches Precision-GI endoscopic automated motorised EUS biopsy device in US
Owens & Minor launches ByramConnect digital health platform for diabetes management
Acrivon Therapeutics receives FDA Breakthrough Device designation for ACR-368 OncoSignature assay
BrainCool secures market approval for BrainCool System in Malaysia
Bioretec Ltd secures CE mark approval for RemeOs Trauma Screw portfolio
Biohit launches FAEX Sample System for stool sample collection
Renalys Pharma completes patient enrolment for Phase III clinical trial of sparsentan
Innocan Pharma's BI Sky Global completes industry standard safety test
ColdVentures partners with Medco Sports Medicine to combat heat stroke